Encore! EP263: The Start-up Who Won Medicare’s AI Contest, Beating Out IBM, Deloitte, and Mayo—A Conversation With Andrew Eye
July 01, 2021
263
32:05

Encore! EP263: The Start-up Who Won Medicare’s AI Contest, Beating Out IBM, Deloitte, and Mayo—A Conversation With Andrew Eye

If I had a nickel for every guest on this show who went on to achieve wild success … TJ Parker from PillPack three years before they were bought by Amazon. Anyway, let me introduce this show with a clip from the recent podcast (EP325) with Dr. Mai Pham. We were talking about the rampant and very open secret of excessive upcoding in Medicare Advantage (MA) that is costing American taxpayers a fortune and is very not correlated with actual spend. Here we go with Dr. Mai Pham: 

Stacey: Do you have any thoughts relative to how you ensure that these MA plans that are becoming vast are still accountable to not game the system? How do you plug loopholes in a way that doesn’t invite additional and more nefarious gaming?

Dr. Pham: My fantasy has always been that CMS can develop, or somebody can develop, a black box machine learning–driven, risk-adjustment algorithm that no one can see into—not even the payer. It would very much level the playing field, assuming that it was developed correctly, appropriately, and you used unbiased data; but that’s the kind of system and extreme solution that I think starts to sound almost necessary given the state of things and the rate of acceleration in upcoding.

So, people may not have noticed that CMS had put out a request for — I think it was a challenge grant, maybe? And they recently announced a couple of winners. They were asking for artificial intelligence–driven approaches to predicting health outcomes, which I believe is just the first shadow approach, the first step that you take in thinking about artificial intelligence–driven risk adjustment.

I also want the audience to understand, it’s not like we’re talking about replacing a really superlative gold standard, right? The majority of the most commonly used risk-adjustment approaches today produce a correlation with actual spend of only like 0.2. This is the best we can do? This is how we’re deciding how we’re going to spend a trillion dollars each year? Surely, we can do better.

And, by the way, the winner of that CMS AI contest was ClosedLoop.ai; and Andrew Eye from ClosedLoop.ai was on the show. Cue Encore Episode here!  

In the original version of this show, there was a whole prelude about whether AI is or is not anything beyond an overused marketing pitch; but I think, in the time-space continuum, we’re beyond that conversation now. Don’t get me wrong, everybody still has AI in their cloud analytics platforms. And some of them are still, as they say, programmed in PowerPoint (that was a joke); but real deals are emerging from the fray.

As mentioned, in this health care podcast I talk with Andrew Eye about AI. (He was born for this job.) Andrew is CEO over at ClosedLoop.ai. ClosedLoop.ai beat out over 300 rivals with their system that forecasts adverse health events and then plops warnings even in the EHR with action steps for clinicians to avoid the calamity in the making.

You can imagine many things that CMS might be contemplating using this tool for, including as a control for false upcoding and all of the financial toxicity that goes along with that. By the way, keep in mind all the top-performing Medicare Advantage plans are using today, right now, some form of advanced analytics and artificial intelligence to risk stratify their populations and predict which members will, without intervention, become high cost in the near term. Others are using AI right now to do the kind of predictive analytics that you need to excel at population health.

I get to ask Andrew some of the hard questions that have been bothering me about all the AI hype, and he set me straight a couple of times. Love it when that happens.

You can learn more at closedloop.ai or by following Andrew (@andreweye) on Twitter. 

Andrew Eye’s executive and entrepreneurial experience spans over 20 years in business to consumer and business to business for start-ups and Fortune 500 companies. Andrew founded and sold three technology companies and today is the CEO and founder of ClosedLoop.ai.

In 2012, Andrew cofounded the mobile software company Boxer. Boxer developed mobile productivity software for individuals and large corporations. Boxer’s flagship email product was downloaded by millions of users and received significant industry praise for its exceptional user interface, including a 2015 Webby Nomination as one of the top 5 productivity applications in the world. Boxer was purchased by VMWare (one of the top 10 largest software companies in the world) in 2015.

Prior to Boxer, Andrew cofounded the cybersecurity firm Ciphent in 2007. Ciphent grew to nearly 100 employees with 1000 customers by 2010 before being acquired by Accuvant (now Optiv). With a three-year growth rate of 8900%, Ciphent was recognized by Inc. magazine as the 16th fastest-growing private company in the United States. During his tenure as SVP of services at Accuvant, Andrew oversaw a $50-million, 200-person organization and was responsible for doubling revenues in 18 months.

Andrew also served as CEO of Bodkin Consulting Group, where he worked with Fortune 500 brands and technology companies to define their interactive marketing strategies. Andrew began his career as a software architect working with NASA, i2 technologies, and the US Marine Corps.

Andrew graduated summa cum laude from Virginia Tech with a degree in management information technology. Andrew lives in Austin, Texas.


04:34 What exactly predictive analytics is.
05:05 The use cases of predictive analytics value.
07:23 The oversimplification of how people think about risk.
09:03 “Did you have an impact or not?”
09:17 The public scorecard for predictive analytics.
13:59 “Explainability is a real hot topic in artificial intelligence, specifically in health care.”
15:24 Data shaming—what’s wrong with it, and why incomplete data are still important.
17:34 The possibilities that machine learning allows for in patient care in health care.
23:45 “Our health care system can’t afford for that level of inefficiency.”
24:57 “It’s not a question of if; it’s a question of when.”
26:04 The diminishing returns of interoperability and more data for machine learning.
29:21 “You’re running your business today, and whatever data you’re using to run your business … you can use it to provide better patient care.”
30:01 Andrew’s advice: Get started now.

healthcare,digital health,closedloop.ai,
|

Episode Support Provided By

Special Thanks to Our 2026 Sustaining Monthly Donors

Kimberly CarlesonDylan YahnBenjamin LightMatt McQuideAnn KempskiSpencer AllenScott TromanhauserMarilyn BartlettSteven ElkinsMatthew Bunte.

Recent Episodes

EP505: The Death of the "What Is Value" Guessing Game for Clinical and Plan Decision-Makers Ready to Move On, With Ahilan Sivaganesan, MD
Relentless Health ValueApril 02, 2026
505
44:0240.31 MB

EP505: The Death of the "What Is Value" Guessing Game for Clinical and Plan Decision-Makers Ready to Move On, With Ahilan Sivaganesan, MD

Listen On Your Favorite App Hello, Relentless Tribe. Thank you so much for showing up today. All right … to start, let me lay out the goal of the episode today. This episode is for you if you are a self-funded employer looking to ensure your members are steered and tiered to real high-value care and...

EP504: A Back-to-Basics Roadmap Through the Perverse Incentives to Advanced Primary Care, With Ryan Jacobs
Relentless Health ValueMarch 26, 2026
504
33:3630.76 MB

EP504: A Back-to-Basics Roadmap Through the Perverse Incentives to Advanced Primary Care, With Ryan Jacobs

Listen On Your Favorite App It's been a while since we started from the beginning, so let's just take stock of the basics in this show, refresh ourselves if you're a longtime listener, or welcome if you're new around here. Today we are digging on and about what I would call the poster child for prov...

INBW46: Relentless Tribe Goings-On With Insights to Outwit the Hot Mess of the Non-Healthcare Market
Relentless Health ValueMarch 19, 202619:3717.96 MB

INBW46: Relentless Tribe Goings-On With Insights to Outwit the Hot Mess of the Non-Healthcare Market

Listen On Your Favorite App This inbetweenisode I wanna try something new for two reasons. One of them is that I need to check this episode off my to-do list because I am crushed for time. I'm going to be headed to Arizona tomorrow for the Collective Health Conference , which will have occurred thre...

EP503: Let's Go From Lazy PPO Networks to Smart Collaboration With Direct-to-Employer Specialty Care, With Ryan Wells; Leo Spector, MD, MBA; and Adam Stavisky
Relentless Health ValueMarch 12, 2026
503
46:1642.35 MB

EP503: Let's Go From Lazy PPO Networks to Smart Collaboration With Direct-to-Employer Specialty Care, With Ryan Wells; Leo Spector, MD, MBA; and Adam Stavisky

Listen On Your Favorite App Today we are digging into something I've said probably way too often: Collaboration is the next breakthrough innovation. And I'm doubling down on this because in the current healthcare landscape, two parties that actually should be talking—like burning up the phone wires ...

EP502: How Some Pretty Wild Medicare Fraud Sabotages ACOs and Also Independent Practices and Could Cost Plan Sponsors Such as Self-insured Employers a Lot of Zeros Downstream, With Brian Machut
Relentless Health ValueMarch 05, 2026
502
38:5835.67 MB

EP502: How Some Pretty Wild Medicare Fraud Sabotages ACOs and Also Independent Practices and Could Cost Plan Sponsors Such as Self-insured Employers a Lot of Zeros Downstream, With Brian Machut

You know, I always kind of wondered what the hackers were doing with all of the medical data that they've managed to get their mitts on over the past, I don't know, however many years. Now, I know at least one thing. If you're a hacker, you can use your stolen medical data to not actually send wildl...

EP501: Speaking of Infusions, Do You Want to Pay $135 or Do You Want to Pay $13,560 for the Exact Same Drug? With Ivana Krajcinovic, PhD
Relentless Health ValueFebruary 26, 2026
501
39:5736.57 MB

EP501: Speaking of Infusions, Do You Want to Pay $135 or Do You Want to Pay $13,560 for the Exact Same Drug? With Ivana Krajcinovic, PhD

Let us chat about today the inches all around us and also about how there is no market in healthcare all at once in this show. Today I am talking with Ivana Krajcinovic. And let me give you some examples of the inches. Two members of a plan get infusions at a hospital. And if these two members had g...

Take Two: EP398: Why Are Commercial Carrier Marketplaces Completely Boring? Maybe Because There Isn't a Marketplace, With Jacob Asher, MD
Relentless Health ValueFebruary 19, 202634:5231.91 MB

Take Two: EP398: Why Are Commercial Carrier Marketplaces Completely Boring? Maybe Because There Isn't a Marketplace, With Jacob Asher, MD

We have been doing a little series called "The Inches Are All Around Us," digging out waste in the $5.6 trillion healthcare sector where half an inch of waste can equal billions of dollars. I'm going to right now introduce another series that is complementary but has a slightly different focus. And ...

Listen and Follow

Sponsored by Aventria Health Group
©2026 BD Bridges LLC. All Rights Reserved.